Iron chelators ICL670 and 311 inhibit HIV-1 transcription
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
HIV-1 replication is induced by an excess of iron and iron chelation by desferrioxamine (DFO) inhibits viral replication by reducing proliferation of infected cells. Treatment of cells with DFO and 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone (311) inhibit expression of proteins that regulate cell-cycle progression, including cycle-dependent kinase 2 (CDK2). Our recent studies showed that CDK2 participates in HIV-1 transcription and viral replication suggesting that inhibition of CDK2 by iron chelators might also affect HIV-1 transcription. Here we evaluated the effect of a clinically approved orally effective iron chelator, 4-[3,5-bis-(hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid (ICL670) and 311 on HIV-1 transcription. Both ICL670 and 311 inhibited Tat-induced HIV-1 transcription in CEM-T cells, 293T and HeLa cells. Neither ICL670 nor 311 induced cytotoxicity at concentrations that inhibited HIV-1 transcription. The chelators decreased cellular activity of CDK2 and reduced HIV-1 Tat phosphorylation by CDK2. Neither ICL670A or 311 decreased CDK9 protein level but significantly reduced association of CDK9 with cyclin T1 and reduced phosphorylation of Ser-2 residues of RNA polymerase II C-terminal domain. In conclusion, our findings add to the evidence that iron chelators can inhibit HIV-1 transcription by deregulating CDK2 and CDK9. Further consideration should be given to the development of iron chelators for future anti-retroviral therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iron status and the outcome of HIV infection: an overview
Gordeuk, V. R., Delanghe, J. R., Langlois, M. R., & Boelaert, J. R. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00134-7 · Cited by 124 · cited 1×
“Increased iron stores correlate with faster HIV-1 progression in HIV-1 positive thalassemia major patients, in HIV-positive patients who were administered oral iron and in HIV-positive subjects with haptoglobin 2–2 polymorphism associated with higher iron stores (Gordeuk et al., 2001).”
BackgroundSelf-citationGeorgiou, N. A., Van Der Bruggen, T., Oudshoorn, M., Hider, R. C., Marx, J. J. M., & Van Asbeck, B. S. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1091.x · Cited by 38 · cited 2×
“The orally active bidentate chelators CP502 and CP511 decreased HIV-1 replication and cellular proliferation in a manner similar to DFO and CP20 (Georgiou et al., 2002).”
Background
Cited by
Viral infection and iron metabolism
Drakesmith, H., & Prentice, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1930 · Cited by 469
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…2003; Valenti et al. 2008; Venturini et al. 2010; Won et al. 2009) and HIV (Boelaert et al. 1996; Butensky James et al. 2009; de Monyé et al. 1999; Debebe et al. 2007; Drakesmith and Prentice 2008; Georgiou et al. 2000; Gordeuk et al. 2001, 2006; Kagu et al. 2007; Ketonen et al. 1996;…”
BackgroundIron metabolism and the innate immune response to infection
Johnson, E. E., & Wessling-Resnick, M. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2011.10.001 · Cited by 253
Synthetic and natural iron chelators: Therapeutic potential and clinical use
Hatcher, H. C., Singh, R. N., Torti, F. M., & Torti, S. V. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.121 · Cited by 242
Metadata
- Authors
- Debebe, Z., Ammosova, T., Jerebtsova, M., Kurantsin-Mills, J., Niu, X., Charles, S., Richardson, D. R., Ray, P. E., Gordeuk, V. R., & Nekhai, S.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 367
- Issue
- 2
- Pages
- 324-333
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W2089674731
- Cited by
- 72
- References
- 2
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Iron chelators ICL670 and 311 inhibit HIV-1 transcription. https://app.cochat.ai/papers/10.1016/j.virol.2007.06.011
- The paper
- Debebe, Z., Ammosova, T., Jerebtsova, M., Kurantsin-Mills, J., Niu, X., Charles, S., Richardson, D. R., Ray, P. E., Gordeuk, V. R., & Nekhai, S. (2007). Iron chelators ICL670 and 311 inhibit HIV-1 transcription. Virology. https://doi.org/10.1016/j.virol.2007.06.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.